Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Real-World Impact of Amiodarone on Apixaban Population Pharmacokinetics in Hospitalized Patients.

Clinical and translational science·2025

Same author

Minimal mathematical model for glycation of albumin.

Clinical biochemistry·2024

Same author

Observation of a positive interference in LC-MS/MS measurement of d<sub>6</sub>-25-OH-vitamin D3.

Clinical mass spectrometry (Del Mar, Calif.)·2024

Same author

Jerk (d(acceleration)/dt) as an operative variable in pneumatic tube transport (PTT).

Laboratory medicine·2024

Same author

Evaluation of the ARK Diagnostics immunoassay for qualitative detection of xylazine in urine.

Journal of analytical toxicology·2024

Same author

Time-of-day dependence of running averages for some components of metabolic panels at our hospital: Relation to strategy for patient-based quality control.

Clinica chimica acta; international journal of clinical chemistry·2024

Search research articles

Related Experiment Video

Updated: May 14, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Decreasing the cutoff for elevated blood lead (EBL) can decrease the screening sensitivity for EBL.

Laura J McCloskey¹, Frank R Bordash, Kathy J Ubben

¹Department of Pathology, Jefferson University Hospitals, Philadelphia, PA 19107, USA.

American Journal of Clinical Pathology

|February 23, 2013

Summary

This summary is machine-generated.

Lowering the elevated blood lead (EBL) threshold reduces screening sensitivity. This change increases misclassifications due to assay imprecision, impacting public health surveillance for lead exposure.

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Related Experiment Videos

Last Updated: May 14, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Area of Science:

Environmental Health
Clinical Chemistry
Public Health Surveillance

Background:

The United States revised the definition of elevated blood lead (EBL) from ≥10 μg/dL to ≥5 μg/dL.
This change may inadvertently decrease the sensitivity of screening tests for detecting EBL.

Purpose of the Study:

To evaluate the impact of the revised EBL definition on screening sensitivity.
To quantify the effect of assay imprecision on EBL detection under the new cutoff.

Main Methods:

Simulated sampling of a representative patient blood lead distribution.
Incorporated lead-dependent assay imprecision to model individual misclassifications.
Calculated screening sensitivity changes relative to the original (cutoff A) and new (cutoff B) EBL thresholds.

Main Results:

Reducing the EBL cutoff from ≥10 μg/dL to ≥5 μg/dL decreased screening sensitivity by 4% to below 90% in the simulated population.
A larger proportion of the EBL population fell near the new, lower cutoff, increasing susceptibility to misclassification by assay imprecision.
The study highlights the critical role of assay imprecision in EBL screening outcomes.

Conclusions:

The revised EBL definition, while intended to identify more cases, can reduce screening sensitivity due to assay variability.
This finding has implications for EBL screening programs nationwide, potentially affecting case identification and public health interventions.
Further research may be needed to optimize EBL screening protocols in light of assay limitations.